Source: Annual Congress 2006 - Management of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. N. Akulova, M. Y. Drobizhev, E. N. Ishchenko, K. A. Baturin, S. I. Ovcharenko (Moscow, Russian Federation). Structure of cooperation and clinical course in asthma model. Eur Respir J 2006; 28: Suppl. 50, 4865

Member's Comments

No comment yet.

Related content which might interest you: Evaluating COPD disease management: application of a theoretical model Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The disease model: implications for clinical practice Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018 Year: 2018 Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006 Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 Clinical course of childhood asthma: a role of disease severity Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008 The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018 Year: 2018 Clinical and functional characteristics of the natural course of COPD Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Is it possible to predict asthma outcomes? A disease model for economic analysis. Source: International Congress 2017 – Asthma management Year: 2017 Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Difficult-to-manage asthma: a need for clinical cooperation Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice" Year: 2013 Effectiveness of different models of maintenance therapy for bronchial asthma (BA) in routine clinical practice Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007 Different definitions in childhood asthma: how dependable is the dependent variable? Source: Eur Respir J 2010; 36: 48-56 Year: 2010 A novel evaluation of the impact of severe allergic asthma in children: The family perspective Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 Role of educational program in combination with observation of asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 519s Year: 2004 Structure and function of small airways in asthma patients revisited Source: Eur Respir Rev, 30 (159) 200186; 10.1183/16000617.0186-2020 Year: 2021 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Predicting the course of sarcoidosis with clinical factors Source: Eur Respir J 2005; 26: Suppl. 49, 32s Year: 2005 Distinct clinical phenotypes of airways disease: a primary-care clinician perspective Source: Eur Respir J 2010; 35: 459 Year: 2010